INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 228 filers reported holding INSMED INC in Q1 2023. The put-call ratio across all filers is 0.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $969 | -30.7% | 38,387 | -53.2% | 0.08% | -39.9% |
Q1 2023 | $1,399 | +12.6% | 82,072 | +32.0% | 0.14% | -10.4% |
Q4 2022 | $1,242 | -99.9% | 62,184 | -27.3% | 0.15% | -36.9% |
Q3 2022 | $1,842,000 | +544.1% | 85,531 | +603.8% | 0.24% | +542.1% |
Q1 2022 | $286,000 | -58.4% | 12,152 | -39.8% | 0.04% | -66.7% |
Q1 2021 | $687,000 | +56.1% | 20,182 | +52.6% | 0.11% | +58.3% |
Q4 2020 | $440,000 | -84.6% | 13,224 | -85.1% | 0.07% | -84.9% |
Q3 2020 | $2,861,000 | +626.1% | 89,029 | +299.1% | 0.48% | +800.0% |
Q3 2019 | $394,000 | -37.0% | 22,310 | +3.7% | 0.05% | -15.9% |
Q1 2019 | $625,000 | +1.1% | 21,513 | +8.5% | 0.06% | +65.8% |
Q4 2017 | $618,000 | +17.9% | 19,824 | +18.0% | 0.04% | +5.6% |
Q3 2017 | $524,000 | +39.4% | 16,794 | -19.0% | 0.04% | +100.0% |
Q4 2015 | $376,000 | -54.9% | 20,742 | -53.8% | 0.02% | -56.1% |
Q3 2015 | $834,000 | – | 44,893 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 5,889,491 | $148,709,648 | 14.07% |
Deep Track Capital, LP | 6,000,000 | $151,500,000 | 5.85% |
Octagon Capital Advisors LP | 1,284,000 | $32,421,000 | 4.98% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 3,446,334 | $87,019,934 | 4.70% |
MPM BioImpact LLC | 527,458 | $13,318,315 | 3.56% |
Novo Holdings A/S | 1,339,304 | $33,817,426 | 2.50% |
Bleichroeder LP | 325,000 | $8,206,250 | 2.02% |
GREAT POINT PARTNERS LLC | 394,872 | $9,970,518 | 1.82% |
Endurant Capital Management LP | 79,471 | $2,006,643 | 1.80% |
SECTORAL ASSET MANAGEMENT INC | 347,392 | $8,771,648 | 1.71% |